查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
DNA 合成市場規模、份額和趨勢分析報告：按服務類型（基因合成、寡核甘酸合成）、應用（研發、治療）、最終用途、地區、細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1178539

DNA 合成市場規模、份額和趨勢分析報告：按服務類型（基因合成、寡核甘酸合成）、應用（研發、治療）、最終用途、地區、細分市場預測，2023-2030 年

DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research And Development, Therapeutics), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

DNA 合成市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球 DNA 合成市場預計將達到 127.6 億美元。 該市場預計從 2023 年到 2030 年的複合年增長率為 19.63%，這是由於人們越來越關注個性化基因組測序以協助患者護理決策。 DNA 合成還有可能通過疾病監測、藥物發現和藥物基因組學等廣泛應用徹底改變生物學研究活動。

COVID-19 大流行對採用基於 mRNA 的疫苗治療 COVID-19 感染和各種類型的癌症產生了積極影響。 mRNA 的可用性推動了對合成 DNA 的需求。 此外，COVID-19 研究的一個主要重點是 DNA 合成。 合成 DNA 用於所有 PCR 分析。 患者應使用 DNA 引物來鑑定樣本中潛在的基因組 DNA。

由於□工程的進步，正在開發各種□促 DNA 合成方法。 它使用□將核酸連接成所需序列，需要進一步優化以實現更廣泛的應用。 許多市場參與者正在嘗試設計新技術，以在最短的周轉時間內高效地□促生產核甘酸。 例如，Ribbon Biolabs 的任務是在 2021 年 5 月合成 10,000 個鹼基對的 DNA 序列，並在 2021 年 12 月實現了 20,000 個鹼基對 DNA 分子的裡程碑。

基因合成具有廣泛的應用，包括具有特定鹼基序列的靶向誘變和所需表型表達的控制。 基因合成是基因工程的基礎，開發具有高特異性的抗體片段極大地提高了抗體的種類和質量。

寡核甘酸合成是在實驗室中生產具有所需定義序列的相對較短的核酸片段。 該技術是一種極其強大的方法，有助於快速、廉價地獲取所需序列的定制寡核甘酸。 公司正在設計他們的寡核甘酸文庫以協助核甘酸合成過程。 例如，2022 年 7 月，Ribbon Biolabs 宣布其已獲得一項美國專利，涉及一種使用 Ribbon Biolabs 多樣化的寡核甘酸庫合成核甘酸分子的方法。 在這種方法中，預先構建了一個寡核甘酸庫以實現高效訪問。

DNA 合成市場報告亮點

按服務類型劃分，寡核甘酸合成在 2022 年所佔份額最大，原因是合成核甘酸鏈在研究中的實用性使其需求不斷增長

按應用劃分，由於生物技術和基於 mRNA 的疫苗等廣泛應用對合成核甘酸的需求，研發部門在 2022 年主導了市場。

在最終用途方面，由於利用生物分子療法的合成核甘酸的應用越來越多，預計生物製藥公司部門在預測期內將快速增長。 對新藥開發需求的增長也對該領域的增長產生了積極影響。

由於生命科學研究的進步和對新型生物治療藥物的需求激增，北美在 2022 年主導了全球市場。

由於對生物研究和新藥發現的需求增加，預計亞太地區將出現顯著增長。 此外，主要市場參與者正尋求憑藉其最新的核甘酸生產專業知識進入亞太市場。

內容

第1章調查方法及範圍

  • 調查範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 目的

第 2 章執行摘要

  • DNA 合成市場：市場展望

第 3 章市場變量、趨勢和範圍

  • 市場趨勢和前景
  • 趨勢分析
    • 服務類型趨勢
    • 應用趨勢
    • 最終用途趨勢
  • 市場細分和範圍
  • 市場動態
    • 市場驅動因素分析
      • 合成生物學領域的快速技術進步
      • 增加對研發 (R&D) 活動的投資
    • 市場製約因素分析
      • 潛在的生物安全、生物安保和倫理問題
      • 嚴格的政府法規和準則
    • 機會分析
  • 2022 年產品滲透率和增長前景圖
  • 商業環境分析
    • DNA 合成市場：SWOT 分析，按因素（政治和法律、經濟和技術）
    • 波特的五力分析
  • 市場份額分析
    • 公司規模
    • 產品組合
    • 戰略舉措
  • 競爭格局
    • 戰略框架
    • 市場參與分類
      • 新/新進入者
      • 成熟的參與者和領導者

第4章服務業務分析

  • 寡核甘酸合成
    • 標準寡核甘酸合成
    • 定制寡核甘酸合成
  • 基因合成
    • 定制基因合成
    • 基因文庫合成

第5章應用分析

  • 研究與開發
  • 診斷
  • 治療學

第 6 章教育用途分析

  • 生物製藥公司
  • 學術和研究機構
  • 委託研究機構

第7章區域業務分析

    • DNA 合成市場：區域差異分析，2022 年和 2030 年
    • 北美
      • 美國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 加拿大
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
    • 歐洲
      • 德國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 英國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 法國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 意大利
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 西班牙
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 丹麥
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 瑞典
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 挪威
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
    • 亞太地區
      • 日本
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 中國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 印度
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 澳大利亞
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 泰國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 韓國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 拉丁美洲 (LATAM)
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 巴西
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 墨西哥
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 阿根廷
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
    • 中東和非洲 (MEA)
      • 南非
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 沙特阿拉伯
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 阿拉伯聯合酋長國
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景
      • 科威特
        • 主要國家動態
        • 監管框架
        • 競爭場景
        • 最近的發展
        • 投資場景

第8章公司簡介

  • 公司簡介
    • Thermo Fisher Scientific, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 扭曲生物科學
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Bioneer 公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 伊頓生物科學
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • LGC 生物搜索技術
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • IBA 有限公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 歐陸科學
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Integrated DNA Technologies, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 昆塔拉生物科學公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 金斯瑞生物科技股份有限公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-009-7

DNA Synthesis Market Growth & Trends:

The global DNA synthesis market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 19.63% from 2023 to 2030 owing to the rising focus on personalized genome sequencing that aids determine patient care. In addition, DNA synthesis has the capability to revolutionize biological research activities for widespread applications in disease monitoring, drug discovery, and pharmacogenomics.

The COVID-19 pandemic positively impacted the adoption of mRNA-based vaccines for the treatment of COVID-19 infection and different types of cancers. The utility of mRNA boosts the demand for synthetic DNA. Furthermore, a major focus of COVID-19 research is DNA synthesis. Synthetic DNA is used in all PCR analyses. Patients need to use a DNA primer to identify any genomic DNA that may be present in the sample.

Progress in enzyme engineering is boosting the development of different approaches for enzymatic DNA synthesis. It involves the use of enzymes to chain the nucleic acids together in the required sequence and requires further optimization for its widespread applications. Many market players are striving to devise novel technologies for efficient enzymatic production of nucleotides in the lowest turnaround time. For instance, in May 2021, Ribbon Biolabs set a mission of synthesizing DNA sequences of 10,000 base pairs and accomplished a milestone of a 20,000 base pair DNA molecule by December 2021.

Gene synthesis has a broad spectrum of applications in targeted mutagenesis with a specific sequence of nucleotides along with the regulation of a desired phenotypic expression. It forms the primary basis of genetic engineering, which has significantly leveraged the scope and quality of antibodies by the development of antibody fragments with high specificity.

Oligonucleotide synthesis is the laboratory-based production of relatively short fragments of nucleic acids in a required definitive sequence. The technique is an extremely robust practice that facilitates rapid and inexpensive access to the custom-made oligonucleotides of the desired sequence. Companies have devised their oligonucleotide libraries to aid their nucleotide synthesis processes. For instance, in July 2022, Ribbon Biolabs declared that it secured a U.S. Patent that comprises Ribbon Biolabs' method for the synthesis of a nucleotide molecule using a diverse library of oligonucleotides. The approach comprises a pre-built library of oligonucleotides for efficient access.

DNA Synthesis Market Report Highlights:

  • By service type, oligonucleotide synthesis held the largest share in 2022 due to the rising demand for synthetic nucleotide strands for their utility in research studies
  • By application, the research and development segment dominated the market in 2022 due to the demand for synthetic nucleotides for a wide spectrum of applications in bioengineering and mRNA-based vaccines
  • By end-use, the biopharmaceutical companies segment is expected to grow rapidly over the forecast period owing to a rise in the applications of synthetic nucleotides to leverage bio-molecular therapies. The rise in the demand for novel drug discovery also positively impacts the growth of this segment
  • North America dominated the global market in 2022 owing to emerging advancements in life sciences research and rapidly growing demand for novel bio-therapeutics in the region
  • Asia Pacific is expected to grow considerably due to a rise in the demand for biological research and novel drug discovery. Moreover, key market players are working towards entering the Asia Pacific market with their modern nucleotide production expertise

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Objectives
    • 1.6.1 Objective 1
    • 1.6.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 DNA synthesis Market: Market Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Trend Analysis
    • 3.2.1 Service Type Trends
    • 3.2.2 Application Trends
    • 3.2.3 End-Use Trends
  • 3.3 Market Segmentation & Scope
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rapid Technological Advancements in the Field of Synthetic Biology
      • 3.4.1.2 Rising Investments Toward Research & Development (R&D) Activities
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Potential Biosafety, Biosecurity, and Ethical Issues
      • 3.4.2.2 Stringent Government Regulations & Guidelines
    • 3.4.3 Opportunity analysis
  • 3.5 Penetration & Growth Prospect Mapping for Products, 2022
  • 3.6 Business Environment Analysis
    • 3.6.1 DNA synthesis Market -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.6.2 Porter's Five Forces Analysis
  • 3.7 Market Share Analysis
    • 3.7.1 Company Size
    • 3.7.2 Product portfolio
    • 3.7.3 Strategic Initiatives
  • 3.8 Competitive Landscape
    • 3.8.1 Strategy Framework
    • 3.8.2 Market Participation Categorization
      • 3.8.2.1 New/ emerging entrants
      • 3.8.2.2 Mature players & leaders

Chapter 4 Services Type Business Analysis

  • 4.1 Oligonucleotide Synthesis
    • 4.1.1 Global DNA synthesis market for oligonucleotide synthesis, 2018 - 2030 (USD Million)
    • 4.1.2 Standard Oligonucleotide Synthesis
      • 4.1.2.1 Global DNA synthesis market for standard oligonucleotide synthesis, 2018 - 2030 (USD Million)
    • 4.1.3 Custom Oligonucleotide Synthesis
      • 4.1.3.1 Global DNA synthesis market for custom oligonucleotide synthesis, 2018 - 2030 (USD Million)
  • 4.2 Gene Synthesis
    • 4.2.1 Global DNA synthesis market for gene synthesis, 2018 - 2030 (USD Million)
    • 4.2.2 Custom Gene Synthesis
      • 4.1.2.1 Global DNA synthesis market for custom gene synthesis, 2018 - 2030 (USD Million)
    • 4.2.3 Gene Library Synthesis
      • 4.1.3.1 Global DNA synthesis market for gene library synthesis, 2018 - 2030 (USD Million)

Chapter 5 Application Analysis

  • 5.1 Research & Development
    • 5.1.1 Global DNA Synthesis Market For Research & Development, 2018 - 2030 (USD Million)
  • 5.2 Diagnostics
    • 5.2.1 Global DNA Synthesis Market For Diagnostics, 2018 - 2030 (USD Million)
  • 5.3 Therapeutics
    • 5.3.1 Global DNA Synthesis Market For Therapeutics, 2018 - 2030 (USD Million)

Chapter 6 Edn-Use Analysis

  • 6.1 Biopharmaceutical Companies
    • 6.1.1 Global DNA Synthesis Market For Biopharmaceutical Companies, 2018 - 2030 (Usd Million)
  • 6.2 Academic & Research Institutes
    • 6.2.1 Global DNA Synthesis Market For Academic& Research Institutes, 2018 - 2030 (Usd Million)
  • 6.3 Contract Research Organizations
    • 6.3.1 Global DNA Synthesis Market For Contract Research Organizations, 2018 - 2030 (Usd Million)

Chapter 7 Regional Business Analysis

  • 7.1 DNA synthesis Market: Regional Movement Analysis, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.2.2.2 Key country Dynamics
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 Competitive Scenario
      • 7.2.2.5 Recent Developments
      • 7.2.2.6 Investments Scenario
    • 7.2.3 Canada
      • 7.2.3.1 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.2.3.2 Key country Dynamics
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.4 Competitive Scenario
      • 7.2.3.5 Recent Developments
      • 7.2.3.6 Investments Scenario
  • 7.3 Europe
    • 7.3.1 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 Key country Dynamics
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 Competitive Scenario
      • 7.3.2.5 Recent Developments
      • 7.3.2.6 Investments Scenario
    • 7.3.3 U.K.
      • 7.3.3.1 U.K. Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Key country Dynamics
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Competitive Scenario
      • 7.3.3.5 Recent Developments
      • 7.3.3.6 Investments Scenario
    • 7.3.4 France
      • 7.3.4.1 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Key country Dynamics
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 Competitive Scenario
      • 7.3.4.5 Recent Developments
      • 7.3.4.6 Investments Scenario
    • 7.3.5 Italy
      • 7.3.5.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 Key country Dynamics
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Competitive Scenario
      • 7.3.5.5 Recent Developments
      • 7.3.5.6 Investments Scenario
    • 7.3.6 Spain
      • 7.3.6.1 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.6.2 Key country Dynamics
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Competitive Scenario
      • 7.3.6.5 Recent Developments
      • 7.3.6.6 Investments Scenario
    • 7.3.7 Denmark
      • 7.3.7.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.7.2 Key country Dynamics
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Competitive Scenario
      • 7.3.7.5 Recent Developments
      • 7.3.7.6 Investments Scenario
    • 7.3.8 Sweden
      • 7.3.8.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.8.2 Key country Dynamics
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Competitive Scenario
      • 7.3.8.5 Recent Developments
      • 7.3.8.6 Investments Scenario
    • 7.3.9 Norway
      • 7.3.9.1 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.9.2 Key country Dynamics
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Competitive Scenario
      • 7.3.9.5 Recent Developments
      • 7.3.9.6 Investments Scenario
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.2.2 Key country Dynamics
      • 7.4.2.3 Regulatory Framework
      • 7.4.2.4 Competitive Scenario
      • 7.4.2.5 Recent Developments
      • 7.4.2.6 Investments Scenario
    • 7.4.3 China
      • 7.4.3.1 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.3.2 Key country Dynamics
      • 7.4.3.3 Regulatory Framework
      • 7.4.3.4 Competitive Scenario
      • 7.4.3.5 Recent Developments
      • 7.4.3.6 Investments Scenario
    • 7.4.4 India
      • 7.4.4.1 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.4.2 Key country Dynamics
      • 7.4.4.3 Regulatory Framework
      • 7.4.4.4 Competitive Scenario
      • 7.4.4.5 Recent Developments
      • 7.4.4.6 Investments Scenario
    • 7.4.5 Australia
      • 7.4.5.1 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.5.2 Key country Dynamics
      • 7.4.5.3 Regulatory Framework
      • 7.4.5.4 Competitive Scenario
      • 7.4.5.5 Recent Developments
      • 7.4.5.6 Investments Scenario
    • 7.4.6 Thailand
      • 7.4.6.1 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.6.2 Key country Dynamics
      • 7.4.6.3 Regulatory Framework
      • 7.4.6.4 Competitive Scenario
      • 7.4.6.5 Recent Developments
      • 7.4.6.6 Investments Scenario
    • 7.4.7 South Korea
      • 7.4.7.1 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.7.2 Key country Dynamics
      • 7.4.7.3 Regulatory Framework
      • 7.4.7.4 Competitive Scenario
      • 7.4.7.5 Recent Developments
      • 7.4.7.6 Investments Scenario
  • 7.5 Latin America (LATAM)
    • 7.5.1 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.1.2 Key country Dynamics
      • 7.5.1.3 Regulatory Framework
      • 7.5.1.4 Competitive Scenario
      • 7.5.1.5 Recent Developments
      • 7.5.1.6 Investments Scenario
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.2.2 Key country Dynamics
      • 7.5.2.3 Regulatory Framework
      • 7.5.2.4 Competitive Scenario
      • 7.5.2.5 Recent Developments
      • 7.5.2.6 Investments Scenario
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.3.2 Key country Dynamics
      • 7.5.3.3 Regulatory Framework
      • 7.5.3.4 Competitive Scenario
      • 7.5.3.5 Recent Developments
      • 7.5.3.6 Investments Scenario
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.4.2 Key country Dynamics
      • 7.5.4.3 Regulatory Framework
      • 7.5.4.4 Competitive Scenario
      • 7.5.4.5 Recent Developments
      • 7.5.4.6 Investments Scenario
  • 7.6 Middle East and Africa (MEA)
    • 7.6.1 Middle East and Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.2.2 Key country Dynamics
      • 7.6.2.3 Regulatory Framework
      • 7.6.2.4 Competitive Scenario
      • 7.6.2.5 Recent Developments
      • 7.6.2.6 Investments Scenario
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.3.2 Key country Dynamics
      • 7.6.3.3 Regulatory Framework
      • 7.6.3.4 Competitive Scenario
      • 7.6.3.5 Recent Developments
      • 7.6.3.6 Investments Scenario
    • 7.6.4 UAE
      • 7.6.4.1 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.4.2 Key country Dynamics
      • 7.6.4.3 Regulatory Framework
      • 7.6.4.4 Competitive Scenario
      • 7.6.4.5 Recent Developments
      • 7.6.4.6 Investments Scenario
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.5.2 Key country Dynamics
      • 7.6.5.3 Regulatory Framework
      • 7.6.5.4 Competitive Scenario
      • 7.6.5.5 Recent Developments
      • 7.6.5.6 Investments Scenario

Chapter 8 Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 Thermo Fisher Scientific, Inc.
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 Twist Bioscience
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Bioneer Corporation
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Eton Bioscience
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 LGC Biosearch Technologie
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 IBA GmbH
      • 8.1.6.1 Company Overview
      • 8.1.6.1 Financial Performance
      • 8.1.6.2 Product Benchmarking
      • 8.1.6.3 Strategic Initiatives
    • 8.1.7 Eurofins Scientific
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Integrated DNA Technologies, Inc.
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Quintara Biosciences
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 GenScript Biotech Corporation
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of Diseases
  • Table 4 Global DNA synthesis Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 6 Global DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 8 North America DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 10 North America DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 Canada DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 16 Canada DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 18 Europe DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 20 Europe DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 23 Germany DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 U.K. DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 U.K. DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 28 France DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 France DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 Italy DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 32 Italy DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 34 Spain DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 35 Spain DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 40 Sweden DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 43 Norway DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 44 Norway DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 50 Japan DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 51 Japan DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 53 China DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 54 China DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 56 India DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 57 India DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59 Australia DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 60 Australia DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 Australia DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 63 Thailand DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Thailand DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65 South Korea DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 South Korea DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 68 Latin America DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 75 Mexico DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 76 Mexico DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 78 Argentina DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 88 South Africa DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 South Africa DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 91 UAE DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 92 UAE DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 DNA Synthesis Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 14 DNA Synthesis Market: Product Key Takeaways
  • Fig. 15 Global DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 16 Global DNA Synthesis Market, for Service Type, 2018 - 2030 (USD Million)
  • Fig. 17 Global DNA Synthesis Market, for Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
  • Fig. 18 Global DNA Synthesis Market, for Standard Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
  • Fig. 19 Global DNA Synthesis Market, for Custom Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
  • Fig. 20 Global DNA Synthesis Market, for Gene Synthesis, 2018 - 2030 (USD Million)
  • Fig. 21 Global DNA Synthesis Market, for Custom Gene Synthesis, 2018 - 2030 (USD Million)
  • Fig. 22 Global DNA Synthesis Market, for Gene Library Synthesis, 2018 - 2030 (USD Million)
  • Fig. 23 Global DNA Synthesis Market, for Application, 2018 - 2030 (USD Million)
  • Fig. 24 Global DNA Synthesis Market, for Research & Development, 2018 - 2030 (USD Million)
  • Fig. 25 Global DNA Synthesis Market, for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 26 Global DNA Synthesis Market, for Therapeutics, 2018 - 2030 (USD Million)
  • Fig. 27 Global DNA Synthesis Market, for End-Use, 2018 - 2030 (USD Million)
  • Fig. 28 Global DNA Synthesis Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 29 Global DNA Synthesis Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 30 Global DNA Synthesis Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Fig. 31 Global DNA Synthesis Market - Regional Outlook, 2022 & 2030
  • Fig. 32 North America DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 38 France DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 43 Norway DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 46 China DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 47 India DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait DNA Synthesis Market, 2018 - 2030 (USD Million)